CapsoVision announced today that the FDA cleared its CapsoCam Plus system for use in pediatric patients aged two and above.
Relief Cardiovascular has closed a $12 million Series A round to help initiate a first-in-human feasibility study for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback